Orthopaedic Surgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2161916, encodeId=535d2161916a2, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：SUBMITTED 26-May-2022 R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022 R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022 R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022 Accept 11-Oct-2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=Keven0327, createdTime=Tue Oct 10 10:35:05 CST 2023, time=2023-10-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2145201, encodeId=edc2214520168, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f38099927, createdName=ms8000000091601804, createdTime=Wed Jun 28 12:27:12 CST 2023, time=2023-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112393, encodeId=e0fd2112393e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;手术;骨科学 经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b5a6442191, createdName=ms4000000449140332, createdTime=Tue Jan 31 15:11:37 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098090, encodeId=a3ff2098090de, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨肿瘤 经验分享：审稿较慢，前后修改8次，1年左右见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63878410668, createdName=ms1000000383355580, createdTime=Wed Nov 02 19:25:23 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229117, encodeId=d138122911e0f, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：手术;骨科;临床 经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=737a1742606, createdName=wangyitian, createdTime=Tue Jun 28 10:25:46 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014924, encodeId=1f0010149243a, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：挺烂，审稿时间长，费用高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a911560212, createdName=zhuujiann, createdTime=Mon Sep 06 07:46:02 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211386, encodeId=ceb11211386e5, content=审稿速度:24.0 | 投稿命中率:75.0 偏重的研究方向：手术;骨科;临床 经验分享：历时近2年，修了8次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMXibIkdO2qQviciaiceHtsKDl1C9ecb6yfc7U077ZkLePUj4C1ibZicbcbKpjJLjROVuGdvvWSJo8n16g/132, createdBy=39635197026, createdName=艾湖蓠, createdTime=Fri Apr 15 11:05:33 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207013, encodeId=bc04120e01368, content=投了三个月了，杳无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c55545880, createdName=ms5000000552394217, createdTime=Tue Mar 29 20:46:12 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200784, encodeId=89a41200e84ba, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Wed Mar 09 08:21:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178994, encodeId=58ed11e8994e1, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Thu Dec 30 21:35:13 CST 2021, time=2021-12-30, status=1, ipAttribution=)]

2023-10-10 Keven0327 来自北京

审稿速度:6.0 | 投稿命中率:50.0
经验分享：SUBMITTED 26-May-2022
R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022
R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022
R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022
Accept 11-Oct-2022

6 0

[GetPortalCommentsPageByObjectIdResponse(id=2161916, encodeId=535d2161916a2, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：SUBMITTED 26-May-2022 R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022 R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022 R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022 Accept 11-Oct-2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=Keven0327, createdTime=Tue Oct 10 10:35:05 CST 2023, time=2023-10-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2145201, encodeId=edc2214520168, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f38099927, createdName=ms8000000091601804, createdTime=Wed Jun 28 12:27:12 CST 2023, time=2023-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112393, encodeId=e0fd2112393e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;手术;骨科学 经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b5a6442191, createdName=ms4000000449140332, createdTime=Tue Jan 31 15:11:37 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098090, encodeId=a3ff2098090de, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨肿瘤 经验分享：审稿较慢，前后修改8次，1年左右见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63878410668, createdName=ms1000000383355580, createdTime=Wed Nov 02 19:25:23 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229117, encodeId=d138122911e0f, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：手术;骨科;临床 经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=737a1742606, createdName=wangyitian, createdTime=Tue Jun 28 10:25:46 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014924, encodeId=1f0010149243a, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：挺烂，审稿时间长，费用高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a911560212, createdName=zhuujiann, createdTime=Mon Sep 06 07:46:02 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211386, encodeId=ceb11211386e5, content=审稿速度:24.0 | 投稿命中率:75.0 偏重的研究方向：手术;骨科;临床 经验分享：历时近2年，修了8次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMXibIkdO2qQviciaiceHtsKDl1C9ecb6yfc7U077ZkLePUj4C1ibZicbcbKpjJLjROVuGdvvWSJo8n16g/132, createdBy=39635197026, createdName=艾湖蓠, createdTime=Fri Apr 15 11:05:33 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207013, encodeId=bc04120e01368, content=投了三个月了，杳无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c55545880, createdName=ms5000000552394217, createdTime=Tue Mar 29 20:46:12 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200784, encodeId=89a41200e84ba, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Wed Mar 09 08:21:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178994, encodeId=58ed11e8994e1, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Thu Dec 30 21:35:13 CST 2021, time=2021-12-30, status=1, ipAttribution=)]

2023-06-28 ms8000000091601804 来自山东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：脊柱
经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？

30 0

[GetPortalCommentsPageByObjectIdResponse(id=2161916, encodeId=535d2161916a2, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：SUBMITTED 26-May-2022 R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022 R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022 R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022 Accept 11-Oct-2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=Keven0327, createdTime=Tue Oct 10 10:35:05 CST 2023, time=2023-10-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2145201, encodeId=edc2214520168, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f38099927, createdName=ms8000000091601804, createdTime=Wed Jun 28 12:27:12 CST 2023, time=2023-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112393, encodeId=e0fd2112393e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;手术;骨科学 经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b5a6442191, createdName=ms4000000449140332, createdTime=Tue Jan 31 15:11:37 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098090, encodeId=a3ff2098090de, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨肿瘤 经验分享：审稿较慢，前后修改8次，1年左右见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63878410668, createdName=ms1000000383355580, createdTime=Wed Nov 02 19:25:23 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229117, encodeId=d138122911e0f, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：手术;骨科;临床 经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=737a1742606, createdName=wangyitian, createdTime=Tue Jun 28 10:25:46 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014924, encodeId=1f0010149243a, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：挺烂，审稿时间长，费用高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a911560212, createdName=zhuujiann, createdTime=Mon Sep 06 07:46:02 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211386, encodeId=ceb11211386e5, content=审稿速度:24.0 | 投稿命中率:75.0 偏重的研究方向：手术;骨科;临床 经验分享：历时近2年，修了8次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMXibIkdO2qQviciaiceHtsKDl1C9ecb6yfc7U077ZkLePUj4C1ibZicbcbKpjJLjROVuGdvvWSJo8n16g/132, createdBy=39635197026, createdName=艾湖蓠, createdTime=Fri Apr 15 11:05:33 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207013, encodeId=bc04120e01368, content=投了三个月了，杳无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c55545880, createdName=ms5000000552394217, createdTime=Tue Mar 29 20:46:12 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200784, encodeId=89a41200e84ba, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Wed Mar 09 08:21:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178994, encodeId=58ed11e8994e1, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Thu Dec 30 21:35:13 CST 2021, time=2021-12-30, status=1, ipAttribution=)]

2023-01-31 ms4000000449140332 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：脊柱;手术;骨科学
经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的

44 0

[GetPortalCommentsPageByObjectIdResponse(id=2161916, encodeId=535d2161916a2, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：SUBMITTED 26-May-2022 R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022 R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022 R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022 Accept 11-Oct-2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=Keven0327, createdTime=Tue Oct 10 10:35:05 CST 2023, time=2023-10-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2145201, encodeId=edc2214520168, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f38099927, createdName=ms8000000091601804, createdTime=Wed Jun 28 12:27:12 CST 2023, time=2023-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112393, encodeId=e0fd2112393e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;手术;骨科学 经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b5a6442191, createdName=ms4000000449140332, createdTime=Tue Jan 31 15:11:37 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098090, encodeId=a3ff2098090de, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨肿瘤 经验分享：审稿较慢，前后修改8次，1年左右见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63878410668, createdName=ms1000000383355580, createdTime=Wed Nov 02 19:25:23 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229117, encodeId=d138122911e0f, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：手术;骨科;临床 经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=737a1742606, createdName=wangyitian, createdTime=Tue Jun 28 10:25:46 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014924, encodeId=1f0010149243a, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：挺烂，审稿时间长，费用高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a911560212, createdName=zhuujiann, createdTime=Mon Sep 06 07:46:02 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211386, encodeId=ceb11211386e5, content=审稿速度:24.0 | 投稿命中率:75.0 偏重的研究方向：手术;骨科;临床 经验分享：历时近2年，修了8次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMXibIkdO2qQviciaiceHtsKDl1C9ecb6yfc7U077ZkLePUj4C1ibZicbcbKpjJLjROVuGdvvWSJo8n16g/132, createdBy=39635197026, createdName=艾湖蓠, createdTime=Fri Apr 15 11:05:33 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207013, encodeId=bc04120e01368, content=投了三个月了，杳无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c55545880, createdName=ms5000000552394217, createdTime=Tue Mar 29 20:46:12 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200784, encodeId=89a41200e84ba, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Wed Mar 09 08:21:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178994, encodeId=58ed11e8994e1, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Thu Dec 30 21:35:13 CST 2021, time=2021-12-30, status=1, ipAttribution=)]

2022-11-02 ms1000000383355580

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：骨肿瘤
经验分享：审稿较慢，前后修改8次，1年左右见刊

53 0

[GetPortalCommentsPageByObjectIdResponse(id=2161916, encodeId=535d2161916a2, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：SUBMITTED 26-May-2022 R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022 R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022 R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022 Accept 11-Oct-2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=Keven0327, createdTime=Tue Oct 10 10:35:05 CST 2023, time=2023-10-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2145201, encodeId=edc2214520168, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f38099927, createdName=ms8000000091601804, createdTime=Wed Jun 28 12:27:12 CST 2023, time=2023-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112393, encodeId=e0fd2112393e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;手术;骨科学 经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b5a6442191, createdName=ms4000000449140332, createdTime=Tue Jan 31 15:11:37 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098090, encodeId=a3ff2098090de, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨肿瘤 经验分享：审稿较慢，前后修改8次，1年左右见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63878410668, createdName=ms1000000383355580, createdTime=Wed Nov 02 19:25:23 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229117, encodeId=d138122911e0f, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：手术;骨科;临床 经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=737a1742606, createdName=wangyitian, createdTime=Tue Jun 28 10:25:46 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014924, encodeId=1f0010149243a, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：挺烂，审稿时间长，费用高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a911560212, createdName=zhuujiann, createdTime=Mon Sep 06 07:46:02 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211386, encodeId=ceb11211386e5, content=审稿速度:24.0 | 投稿命中率:75.0 偏重的研究方向：手术;骨科;临床 经验分享：历时近2年，修了8次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMXibIkdO2qQviciaiceHtsKDl1C9ecb6yfc7U077ZkLePUj4C1ibZicbcbKpjJLjROVuGdvvWSJo8n16g/132, createdBy=39635197026, createdName=艾湖蓠, createdTime=Fri Apr 15 11:05:33 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207013, encodeId=bc04120e01368, content=投了三个月了，杳无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c55545880, createdName=ms5000000552394217, createdTime=Tue Mar 29 20:46:12 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200784, encodeId=89a41200e84ba, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Wed Mar 09 08:21:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178994, encodeId=58ed11e8994e1, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Thu Dec 30 21:35:13 CST 2021, time=2021-12-30, status=1, ipAttribution=)]

2022-06-28 wangyitian

审稿速度:24.0 | 投稿命中率:25.0
偏重的研究方向：手术;骨科;临床
经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。

69 0

[GetPortalCommentsPageByObjectIdResponse(id=2161916, encodeId=535d2161916a2, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：SUBMITTED 26-May-2022 R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022 R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022 R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022 Accept 11-Oct-2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=Keven0327, createdTime=Tue Oct 10 10:35:05 CST 2023, time=2023-10-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2145201, encodeId=edc2214520168, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f38099927, createdName=ms8000000091601804, createdTime=Wed Jun 28 12:27:12 CST 2023, time=2023-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112393, encodeId=e0fd2112393e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;手术;骨科学 经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b5a6442191, createdName=ms4000000449140332, createdTime=Tue Jan 31 15:11:37 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098090, encodeId=a3ff2098090de, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨肿瘤 经验分享：审稿较慢，前后修改8次，1年左右见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63878410668, createdName=ms1000000383355580, createdTime=Wed Nov 02 19:25:23 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229117, encodeId=d138122911e0f, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：手术;骨科;临床 经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=737a1742606, createdName=wangyitian, createdTime=Tue Jun 28 10:25:46 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014924, encodeId=1f0010149243a, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：挺烂，审稿时间长，费用高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a911560212, createdName=zhuujiann, createdTime=Mon Sep 06 07:46:02 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211386, encodeId=ceb11211386e5, content=审稿速度:24.0 | 投稿命中率:75.0 偏重的研究方向：手术;骨科;临床 经验分享：历时近2年，修了8次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMXibIkdO2qQviciaiceHtsKDl1C9ecb6yfc7U077ZkLePUj4C1ibZicbcbKpjJLjROVuGdvvWSJo8n16g/132, createdBy=39635197026, createdName=艾湖蓠, createdTime=Fri Apr 15 11:05:33 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207013, encodeId=bc04120e01368, content=投了三个月了，杳无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c55545880, createdName=ms5000000552394217, createdTime=Tue Mar 29 20:46:12 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200784, encodeId=89a41200e84ba, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Wed Mar 09 08:21:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178994, encodeId=58ed11e8994e1, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Thu Dec 30 21:35:13 CST 2021, time=2021-12-30, status=1, ipAttribution=)]

2021-09-06 zhuujiann

审稿速度:6.0 | 投稿命中率:25.0
经验分享：挺烂，审稿时间长，费用高。

236 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161916, encodeId=535d2161916a2, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：SUBMITTED 26-May-2022 R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022 R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022 R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022 Accept 11-Oct-2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=Keven0327, createdTime=Tue Oct 10 10:35:05 CST 2023, time=2023-10-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2145201, encodeId=edc2214520168, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f38099927, createdName=ms8000000091601804, createdTime=Wed Jun 28 12:27:12 CST 2023, time=2023-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112393, encodeId=e0fd2112393e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;手术;骨科学 经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b5a6442191, createdName=ms4000000449140332, createdTime=Tue Jan 31 15:11:37 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098090, encodeId=a3ff2098090de, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨肿瘤 经验分享：审稿较慢，前后修改8次，1年左右见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63878410668, createdName=ms1000000383355580, createdTime=Wed Nov 02 19:25:23 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229117, encodeId=d138122911e0f, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：手术;骨科;临床 经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=737a1742606, createdName=wangyitian, createdTime=Tue Jun 28 10:25:46 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014924, encodeId=1f0010149243a, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：挺烂，审稿时间长，费用高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a911560212, createdName=zhuujiann, createdTime=Mon Sep 06 07:46:02 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211386, encodeId=ceb11211386e5, content=审稿速度:24.0 | 投稿命中率:75.0 偏重的研究方向：手术;骨科;临床 经验分享：历时近2年，修了8次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMXibIkdO2qQviciaiceHtsKDl1C9ecb6yfc7U077ZkLePUj4C1ibZicbcbKpjJLjROVuGdvvWSJo8n16g/132, createdBy=39635197026, createdName=艾湖蓠, createdTime=Fri Apr 15 11:05:33 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207013, encodeId=bc04120e01368, content=投了三个月了，杳无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c55545880, createdName=ms5000000552394217, createdTime=Tue Mar 29 20:46:12 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200784, encodeId=89a41200e84ba, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Wed Mar 09 08:21:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178994, encodeId=58ed11e8994e1, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Thu Dec 30 21:35:13 CST 2021, time=2021-12-30, status=1, ipAttribution=)]

2022-04-15 艾湖蓠

审稿速度:24.0 | 投稿命中率:75.0
偏重的研究方向：手术;骨科;临床
经验分享：历时近2年，修了8次。

70 0

[GetPortalCommentsPageByObjectIdResponse(id=2161916, encodeId=535d2161916a2, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：SUBMITTED 26-May-2022 R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022 R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022 R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022 Accept 11-Oct-2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=Keven0327, createdTime=Tue Oct 10 10:35:05 CST 2023, time=2023-10-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2145201, encodeId=edc2214520168, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f38099927, createdName=ms8000000091601804, createdTime=Wed Jun 28 12:27:12 CST 2023, time=2023-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112393, encodeId=e0fd2112393e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;手术;骨科学 经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b5a6442191, createdName=ms4000000449140332, createdTime=Tue Jan 31 15:11:37 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098090, encodeId=a3ff2098090de, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨肿瘤 经验分享：审稿较慢，前后修改8次，1年左右见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63878410668, createdName=ms1000000383355580, createdTime=Wed Nov 02 19:25:23 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229117, encodeId=d138122911e0f, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：手术;骨科;临床 经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=737a1742606, createdName=wangyitian, createdTime=Tue Jun 28 10:25:46 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014924, encodeId=1f0010149243a, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：挺烂，审稿时间长，费用高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a911560212, createdName=zhuujiann, createdTime=Mon Sep 06 07:46:02 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211386, encodeId=ceb11211386e5, content=审稿速度:24.0 | 投稿命中率:75.0 偏重的研究方向：手术;骨科;临床 经验分享：历时近2年，修了8次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMXibIkdO2qQviciaiceHtsKDl1C9ecb6yfc7U077ZkLePUj4C1ibZicbcbKpjJLjROVuGdvvWSJo8n16g/132, createdBy=39635197026, createdName=艾湖蓠, createdTime=Fri Apr 15 11:05:33 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207013, encodeId=bc04120e01368, content=投了三个月了，杳无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c55545880, createdName=ms5000000552394217, createdTime=Tue Mar 29 20:46:12 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200784, encodeId=89a41200e84ba, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Wed Mar 09 08:21:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178994, encodeId=58ed11e8994e1, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Thu Dec 30 21:35:13 CST 2021, time=2021-12-30, status=1, ipAttribution=)]

2022-03-29 ms5000000552394217

投了三个月了，杳无音讯

77 0

[GetPortalCommentsPageByObjectIdResponse(id=2161916, encodeId=535d2161916a2, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：SUBMITTED 26-May-2022 R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022 R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022 R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022 Accept 11-Oct-2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=Keven0327, createdTime=Tue Oct 10 10:35:05 CST 2023, time=2023-10-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2145201, encodeId=edc2214520168, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f38099927, createdName=ms8000000091601804, createdTime=Wed Jun 28 12:27:12 CST 2023, time=2023-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112393, encodeId=e0fd2112393e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;手术;骨科学 经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b5a6442191, createdName=ms4000000449140332, createdTime=Tue Jan 31 15:11:37 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098090, encodeId=a3ff2098090de, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨肿瘤 经验分享：审稿较慢，前后修改8次，1年左右见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63878410668, createdName=ms1000000383355580, createdTime=Wed Nov 02 19:25:23 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229117, encodeId=d138122911e0f, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：手术;骨科;临床 经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=737a1742606, createdName=wangyitian, createdTime=Tue Jun 28 10:25:46 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014924, encodeId=1f0010149243a, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：挺烂，审稿时间长，费用高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a911560212, createdName=zhuujiann, createdTime=Mon Sep 06 07:46:02 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211386, encodeId=ceb11211386e5, content=审稿速度:24.0 | 投稿命中率:75.0 偏重的研究方向：手术;骨科;临床 经验分享：历时近2年，修了8次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMXibIkdO2qQviciaiceHtsKDl1C9ecb6yfc7U077ZkLePUj4C1ibZicbcbKpjJLjROVuGdvvWSJo8n16g/132, createdBy=39635197026, createdName=艾湖蓠, createdTime=Fri Apr 15 11:05:33 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207013, encodeId=bc04120e01368, content=投了三个月了，杳无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c55545880, createdName=ms5000000552394217, createdTime=Tue Mar 29 20:46:12 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200784, encodeId=89a41200e84ba, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Wed Mar 09 08:21:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178994, encodeId=58ed11e8994e1, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Thu Dec 30 21:35:13 CST 2021, time=2021-12-30, status=1, ipAttribution=)]

2022-03-09 ms7000002026024217

审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向：临床
经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半

71 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161916, encodeId=535d2161916a2, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：SUBMITTED 26-May-2022 R1 Major Revision 15-Jun-2022 SUBMITTED 23-Jun-2022 R2 Major Revision 10-Jul-2022 SUBMITTED 06-Sep-2022 R3 Major Revision 29-Sep-2022 SUBMITTED 10-Oct-2022 Accept 11-Oct-2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=Keven0327, createdTime=Tue Oct 10 10:35:05 CST 2023, time=2023-10-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2145201, encodeId=edc2214520168, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：脊柱 经验分享：一次大修一次小修，审稿时间基本都是一个月。目前交稿提交一周了，没有新消息，不知道本杂志从接收到见刊一般都是经过多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10f38099927, createdName=ms8000000091601804, createdTime=Wed Jun 28 12:27:12 CST 2023, time=2023-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112393, encodeId=e0fd2112393e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;手术;骨科学 经验分享：好多人说审稿慢，但是我觉得还挺快啊，初审半个月给意见，返修2次，每次返回去一周内就返回意见了，校刊的时候刚好遇上疫情放开，拖了3周，然后立马就online了，我觉着还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b5a6442191, createdName=ms4000000449140332, createdTime=Tue Jan 31 15:11:37 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2098090, encodeId=a3ff2098090de, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨肿瘤 经验分享：审稿较慢，前后修改8次，1年左右见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63878410668, createdName=ms1000000383355580, createdTime=Wed Nov 02 19:25:23 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229117, encodeId=d138122911e0f, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：手术;骨科;临床 经验分享：骨科临床文章，投稿到接收14个月，共修6次，2大4小。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=737a1742606, createdName=wangyitian, createdTime=Tue Jun 28 10:25:46 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014924, encodeId=1f0010149243a, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：挺烂，审稿时间长，费用高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a911560212, createdName=zhuujiann, createdTime=Mon Sep 06 07:46:02 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211386, encodeId=ceb11211386e5, content=审稿速度:24.0 | 投稿命中率:75.0 偏重的研究方向：手术;骨科;临床 经验分享：历时近2年，修了8次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMXibIkdO2qQviciaiceHtsKDl1C9ecb6yfc7U077ZkLePUj4C1ibZicbcbKpjJLjROVuGdvvWSJo8n16g/132, createdBy=39635197026, createdName=艾湖蓠, createdTime=Fri Apr 15 11:05:33 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207013, encodeId=bc04120e01368, content=投了三个月了，杳无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c55545880, createdName=ms5000000552394217, createdTime=Tue Mar 29 20:46:12 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200784, encodeId=89a41200e84ba, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：目前一审周期平均约3-4个月，接收1年，见刊1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Wed Mar 09 08:21:08 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178994, encodeId=58ed11e8994e1, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50645573965, createdName=ms7000002026024217, createdTime=Thu Dec 30 21:35:13 CST 2021, time=2021-12-30, status=1, ipAttribution=)]

2021-12-30 ms7000002026024217

审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向：临床
经验分享：不了解情况第一次投，邀请审稿人慢，审稿极慢，

101 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务